Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction
about
Role of Nutraceuticals in Hypolipidemic TherapyA review of the rationale for additional therapeutic interventions to attain lower LDL-C when statin therapy is not enoughA controversial step forward: A commentary on the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults.MediterrAsian Diet Products That Could Raise HDL-Cholesterol: A Systematic ReviewBeneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT.Red yeast rice induces less muscle fatigue symptom than simvastatin in dyslipidemic patients: a single center randomized pilot trial.Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol.Traditional Chinese medicine for lipid metabolism disorders.Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS).In Vivo Hypocholesterolemic Effect of MARDI Fermented Red Yeast Rice Water Extract in High Cholesterol Diet Fed Mice.Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trialEvidence of lifestyle modification in the management of hypercholesterolemia.Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic ratsIntegrative Treatments to Reduce Risk for Cardiovascular DiseaseRed yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial.Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia.The Effect of Elevated Triglycerides on the Onset and Progression of Coronary Artery Disease: A Retrospective Chart Review.A systematic review of xuezhikang, an extract from red yeast rice, for coronary heart disease complicated by dyslipidemiaEfficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled StudyBergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective StudyInteraction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of LovastatinCall to action: cardiovascular disease in Asian Americans: a science advisory from the American Heart Association.A Novel Medical Treatment for Lipid Control in Patients with Unstable Angina Pectoris and Statin-Induced Liver Dysfunction.Isoflavones and phytosterols contained in Xuezhikang capsules modulate cholesterol homeostasis in high-fat diet mice.Integrative Western and chinese medicine on coronary heart disease: where is the orientation?Assessment of the reporting quality of randomized controlled trials on treatment of coronary heart disease with traditional chinese medicine from the chinese journal of integrated traditional and Western medicine: a systematic reviewXuezhikang therapy increases miR-33 expression in patients with low HDL-C levelsImpact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study in rats.The role of red yeast rice for the physician.Traditional Chinese medication for cardiovascular disease.Non-traditional dosing of statins in statin-intolerant patients-is it worth a try?Red yeast rice for the treatment of dyslipidemia.The effects of red yeast rice dietary supplement on blood pressure, lipid profile, and C-reactive protein in hypertension: A systematic review.Nutraceuticals: Definition and Epidemiological Rationale for Their Use in Clinical Practice.Red Yeast Rice.Xuezhikang reduced arterial stiffness in patients with essential hypertension: a preliminary study.Atherosclerosis: an integrative East-west medicine perspective.Experimental studies on the hypolipidemic and haematological properties of aqueous leaf extract of cleistopholis patens benth. & diels. (Annonacae) in hypercholesterolemic rats.HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study.
P2860
Q26776125-9D0A5E91-3DF2-4283-8F3D-B7022BC8F5B3Q26824249-0F7E4D85-EF17-464A-8CCA-5BE907E18D9DQ27691368-4BF215C6-5D7E-4D62-B40E-EECF33DCEF27Q28070287-9BE06AF8-D9A4-4882-9547-955980B1ED48Q28252010-1338E96E-426A-4445-8FE4-D838789B69A9Q31101617-C4D476D7-FA9B-43E2-89A2-C81830390A44Q33706945-F5548FA2-540D-4594-AE0E-439AF9D2171DQ33724722-7ED6D755-85D9-4EA7-A737-F95A4640F0C2Q33733077-6A830F20-996B-449B-8C91-E324A50D974CQ33751578-A3A4BAB0-16C3-409D-BB52-20AB64996998Q33852227-8CF577F5-3301-4AE4-BF8C-CD276EB57063Q33988933-8AB30024-0322-4F34-9BB2-477973FCBAFBQ34301108-FDF264CA-031C-46A0-BBD7-EB421B30BC5EQ34722658-C596B26E-B423-4812-9ED2-BEEC13BBCE77Q34730309-9F90AE09-1FEC-4675-B450-9996862BF74FQ34834399-9B6FB333-1AC0-41B1-90E2-3F30128FF1A6Q34990271-887C9AE9-E74D-4B42-9613-4092D8B5937CQ35855308-81D5C416-60C6-4E46-9127-5E4F8DA7C7B3Q35903944-6F1B46DC-567C-4B44-B1A2-04FB8F2E5D24Q36278238-10B3984F-1BD6-4AB0-8648-BC3B88017D7FQ36432198-74841583-86CA-422F-83E9-60416FB09783Q36444037-F25FF882-4274-4813-9742-BE555BAC7081Q36498650-A4359DF4-A410-4384-93C7-B07BA456AB23Q36721590-62FCE156-D6E1-48C8-A004-7D91C0456F8DQ36751979-2E2A08DD-79CD-4AF3-BCAA-B039F24CAFD6Q37139739-668C153B-B69F-4256-8582-29997409019AQ37525326-7838FFAB-323E-4171-A7E9-188FCD339721Q37586749-4C907858-036C-4312-B59A-F0CF856ECCEAQ37596775-F71EE0B7-7AAF-4C98-9779-EFAE1EAB410BQ37808130-C8506663-C1AD-4D4D-B978-C9FCF16F9612Q38266691-EEBEC835-A72C-46C1-99D6-F9D9D65D2D0AQ38272551-3A4650D5-33B5-4A86-AB44-3893BFF792F9Q38366473-1DA43522-0D9F-4B16-BEE4-E22BD07F19BFQ38388529-3C4FDFF6-9FBE-4143-AAC7-F81D17621FDEQ38451985-82EA421F-6AC9-4E90-8695-B7A717F8415BQ38931130-221E25D2-FB75-4338-A6DE-285E0D17BE43Q41586052-32B95D78-04AF-43F8-B5D8-A394D99D192BQ42059195-4A377A6E-D3F7-41EA-8780-D400DEDBBC30Q42356191-BB8293A5-B42B-4819-B4F8-0ED62B2AB706Q42968447-F5840551-9A3E-4753-AD61-DAAEBB46BF07
P2860
Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Effect of Xuezhikang, an extra ...... previous myocardial infarction
@ast
Effect of Xuezhikang, an extra ...... previous myocardial infarction
@en
Effect of Xuezhikang, an extra ...... previous myocardial infarction
@nl
type
label
Effect of Xuezhikang, an extra ...... previous myocardial infarction
@ast
Effect of Xuezhikang, an extra ...... previous myocardial infarction
@en
Effect of Xuezhikang, an extra ...... previous myocardial infarction
@nl
prefLabel
Effect of Xuezhikang, an extra ...... previous myocardial infarction
@ast
Effect of Xuezhikang, an extra ...... previous myocardial infarction
@en
Effect of Xuezhikang, an extra ...... previous myocardial infarction
@nl
P2093
P3181
P1476
Effect of Xuezhikang, an extra ...... previous myocardial infarction
@en
P2093
David M Capuzzi
John M Morgan
Osvaldo A Brusco
Shuiping Zhao
Wenrong Kou
Yangfeng Wu
Zongliang Lu
P304
P3181
P356
10.1016/J.AMJCARD.2008.02.056
P407
P577
2008-06-15T00:00:00Z